SELLAS Life Sciences Group (RXK3) Q2 2026 Earnings Report
DE:RXK3 Q2 2026 EPS Results
- Actual EPS
- -EUR 0.04
- Consensus EPS
- -EUR 0.04
- Beat/Miss
- Missed by -EUR 0.00
- One Year Ago EPS
- -EUR 0.06
DE:RXK3 Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/11/2026
- Time
- After Close
- Conference Call
- Tuesday, August 11, 2026
DE:RXK3 Upcoming Earnings
SELLAS Life Sciences Group's next earnings date is estimated for November 18, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:RXK3 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 18, 2026 | 2026 (Q3) | -0.04- | -0.05 | ― | ― |
| Aug 11, 2026 | 2026 (Q2) | -0.04-0.04 | -0.06 | 28.57% (+0.02) | |
| May 12, 2026 | 2026 (Q1) | -0.05-0.04 | -0.06 | 28.57% (+0.02) | |
| Mar 19, 2026 | 2025 (Q4) | -0.06-0.04 | -0.05 | 16.67% (+0.01) | |
| Nov 12, 2025 | 2025 (Q3) | -0.07-0.05 | -0.09 | 40.00% (+0.04) | |
| Aug 12, 2025 | 2025 (Q2) | -0.07-0.06 | -0.12 | 46.15% (+0.05) | |
| May 13, 2025 | 2025 (Q1) | -0.09-0.06 | -0.19 | 66.67% (+0.13) | |
| Mar 20, 2025 | 2024 (Q4) | -0.10-0.05 | -0.21 | 73.91% (+0.15) | |
| Nov 13, 2024 | 2024 (Q3) | -0.11-0.09 | -0.3 | 69.70% (+0.21) | |
| Aug 13, 2024 | 2024 (Q2) | -0.15-0.12 | -0.28 | 58.06% (+0.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
